The Centers for Medicare & Medicaid Services released the final 2023 Notice of Benefit and Payment Parameters, the annual rule outlining key policies for the individual and group health insurance markets for plan year 2023 and beyond.
The United States continues to face a behavioral health crisis that has worsened due to the COVID-19 pandemic.
After years of government skepticism and enforcement activity targeting physician-owned medical device companies, a recent favorable advisory opinion by the Office of Inspector General for the U.S. Department of Health & Human Services may offer a degree of comfort to certain manufacturers of ...
On April 7, the Centers for Medicare & Medicaid Services released its highly anticipated final National Coverage Determination (NCD) for Aduhelm and other similar therapies in the pipeline for Alzheimer’s disease.
The IHE’s purpose is to provide early, preventive health risk assessments within the home setting for MA beneficiaries.
On April 5, President Biden held an event at the White House celebrating coverage gains since the enactment of the Affordable Care Act.
The temporary regulatory flexibilities implemented during the PHE expanded program eligibility and enrollment, enhanced remote service delivery options, authorized care delivery in alternative care sites, and much more.
After weeks of negotiations and months of temporary stopgap funding bills since the federal fiscal year started in October 2021, on Tuesday, the President signed the Consolidated Appropriations Act, 2022.
After weeks of negotiations and months of temporary stopgap funding bills since the federal fiscal year started in October 2021, on Tuesday the President signed the Consolidated Appropriations Act, 2022.
Prior to the COVID-19 pandemic, states typically required providers to be licensed in the state(s) where they were practicing.